Expert panel consensus was used to develop evidence-based process indicators that were independent risk factors for the main clinical outcome parameters of length of stay in the intensive care unit (ICU) and mortality. In a retrospective, matched data analysis of patients from five ICUs at a tertiary university hospital, agreed process indicators (sedation monitoring, pain monitoring, mean arterial pressure [MAP] ≥ 60 mmHg, tidal volume [TV] ≤ 6 ml/kg body weight, peak inspiratory pressure [PIP] ≤ 35 cmH 2 O and blood glucose [BG] ≥ 80 and ≤ 130 mg/dl) were validated using a prospective dataset of 4445 consecutive patients. After matching for age, sex and ICU, 634 patients were analysed. Logistic regression of the 634 patients showed that monitoring analgesia and sedation, MAP ≥ 60 mmHg and BG ≥ 80 mg/dl were relevant for survival. Linear regression of the 634 patients showed that analgesia monitoring, PIP ≤ 35 cmH 2 O and TV ≤ 6 ml/kg were associated with reduced length of ICU stay. Linear regression on all 4445 patients showed analgesia, sedation monitoring, MAP ≥ 60 mmHg, BG ≥ 80 mg/dl and ≤ 130 mg/dl, PIP ≤ 35 cmH 2 O and TV ≤ 6 ml/kg were associated with reduced length of ICU stay, indicating that adherence to evidence-based key process indicators may reduce mortality and length of ICU stay. KEY WORDS: CRITICAL CARE; INTENSIVE CARE UNIT; OUTCOME; MORTALITY; QUALITY IMPROVEMENT; KEY PERFORMANCE INDICATOR M Kastrup, V von Dossow, M Seeling et al. Key performance indicators in intensive care medicine M Kastrup, V von Dossow, M Seeling et al. Key performance indicators in intensive care medicine delivering intensive care medicine and to validate these indicators in terms of mortality rates and length of stay in the ICU. M Kastrup, V von Dossow, M Seeling et al. Key performance indicators in intensive care medicine
Introduction
In Germany there are 1400 intensive care units (ICUs), generating approximately 6.6 million ICU days and 5.5 billion Euros in annual costs. 1 ICU mortality ranges from 8% to 33% and hospital mortality from 11% to 64%. 2 There is evidence from guideline implementation research that evidencebased therapies and organizational characteristics are associated with improved outcomes for ICU patients. 3 Small improvements on a large scale can save more lives and reduce mortality to a much greater extent than major improvements in *M Kastrup and V von Dossow contributed equally as first authors. only selected centres. 4 Recently, de Vos et al. 5 selected 11 indicators in a consensus procedure and feasibility study. Evidence of the validity of process indicators is, however, lacking. In a critical appraisal of the literature of quality indicators for ICU practice and consensus decision, Berenholtz et al. 6 identified 18 quality indicators, of which only five were supported by explicit high-quality evidence. Implementation of the sepsis bundle of the Surviving Sepsis Campaign was associated with improved outcome (in this context a bundle is a group of interventions related to a disease process that result in better outcomes when executed together than when implemented individually). 7 Valid quality indicators are necessary to assess how effectively existing evidence is translated from guidelines into practice 8 Three types of quality indicators can be distinguished: those referring (i) to the 'process' of medical care, (ii) to the 'structure' of medical care, and (iii) to the 'outcome' of delivered care. 9 Quality indicators should preferably be developed using systematic methods 10 and should be easy to record electronically. The need for quality indicators in evidence-based medicine is already recognized, but the search for the most suitable indicators relevant to intensive care medicine continues, 10 -12 and little is known about how the implementation of these indicators in clinical practice might influence the processes.
Efforts to improve outcomes in intensive care medicine across the USA have led to a Joint Commission on the Accreditation of Healthcare Organizations (JCAHO), which is charged with enforcing ICU core measures. 13 These measures are intended mainly to decrease infectious complications and certain complications associated with critical illness. The JCAHO suspended the implementation of data collection from 1 July 2005. 14 The practical relevance of these measures for the physician is to allow them to monitor the processes they are using in the ICU. In reality, however, the structure is often mandated and cannot be changed by the physician, and the outcome is often a sequela of structure and process. Thus, physicians can only change the process and they require help to decide which process indicators are relevant for determining outcome. The relevant process indicators require a feedback mechanism. They are, therefore, performance indicators, defined as measurable elements of practice performance (for which there is evidence or consensus) that can be used to assess the quality of care provided and, if necessary, change it. An important requirement of a good performance indicator is that it can be influenced by the provider whose performance is being measured. 15 In Europe, the Spanish Society of Intensive and Critical Medicine conducted a project called 'Quality Indicators in the Critical Patient' in 2006 and developed 120 key performance indicators as a tool to measure common practice and to evaluate the efficacy of clinical measures. 12 Many of these key performance indicators are difficult to record and require additional staff in order to acquire all the data required. For this set of performance indicators, the data were collected at different intervals and, even though most of the parameters are important quality indicators, it is questionable whether the collection and benchmarking of all these data can change the care process during an individual patient's stay in hospital. The aim of the present study was, therefore, to define a small set of practical key performance indicators that are related to the process of
Patients and methods

STUDY CENTRES
This study was performed on patients who had attended at least one of five surgical ICUs at the Charité University Medicine Berlin. It was approved by the Institutional Review Board of the Charité University Medicine Berlin, which waived the need for individual patient informed consent because confidentiality was guaranteed, no interventions were performed and only routine clinical data were collected. The five ICUs are run by the Department of Anaesthesiology and Intensive Care Medicine of the Charité University Medicine Berlin, and comprise two interdisciplinary surgical ICUs, one ICU that primarily treats patients after cardiac surgery, one primarily neurosurgical/neurology ICU and one ICU primarily specialized in acute respiratory distress syndrome.
STUDY DESIGN
This was a retrospective, matched-cohort study (one patient, one control) using a prospectively collected database. All consecutive patients who attended at least one of the five participating ICUs between 4 July 2005 and 10 October 2007 were eligible as potential participants. The sample size was chosen to provide a cohort of > 200 patients so that a multivariate analysis of mortality could be performed. A matched control patient who was discharged alive from the ICU was designated for each patient who died during the ICU stay, matched according to age, sex and ICU ward.
All patient records were accessed via an electronic information system (patient data management system [PDMS]), provided by the Computer Organized Patient Report Assistant (COPRA ® , Sasbachwalden, Germany). Data were extracted by structured query language questioning of the database. A flow diagram describing the process of patient record inclusion in the univariate and multivariate analyses is shown in Fig. 1 . The PDMS is designed so that there is no possibility of manually changing the data or of entering missing values after discharge of a patient from the ICU. To ensure confidentiality, patient identifiers were not collected.
KEY PERFORMANCE INDICATORS
In early 2007, an Institutional Board (Steering Committee) at the Department of Anaesthesiology and Intensive Care, Charité University Medicine Berlin, comprising the department head, senior department staff, the ICU attending physicians and nurse representatives, met to establish a predefined bundle of evidence-based key performance indicators based on data that were easily accessible as they were part of electronic patient records. Besides administrative data, that were already being used, and the use of different scores for assessing the depth of sedation and pain, major criteria for the selection of indicators were: (i) no additional workload required for documentation; (ii) the ability of the performance indicator to be influenced by the care provider, and (iii) the potential ability for a change to be made during the course of treatment if the results are presented to users within the electronic documentation system.
During the course of several meetings, specific goals were set for each domain of ICU treatment, i.e. for cerebral, cardiovascular, pulmonary and gastrointestinal systems. Specific key process indicators were chosen to assess performance within each domain ( Table 1 ). Additional criteria for defining the performance indicators were: (i) the assumed importance for outcome as shown by evidence-based medicine; (ii) the existence of a standard operating procedure for the issuance of the indicator; and (iii) easy electronic accessibility of the parameters. An external audit by experienced intensive care specialists was performed to complete the development process.
During the study period, standard operating procedures were available in all the investigated ICUs. 16 To evaluate the effect on outcome, the frequencies of observations were established by collecting all the data from each patient's electronic record. Defined specifications and deviations from the treatment goal are shown in Table 1 . The frequencies of these defined deviations were counted after the extraction of data from the electronic patient files. Deviations from the predefined treatment goals were considered to have occurred when adrift of the goal values for at least 1 day.
The following data were collected from the electronic patient records: age (years); sex; duration of ICU stay (days); duration of ventilator support (h); all recorded tidal volumes (ml/kg); all recorded peak inspiratory pressures (cmH 2 O); all mean arterial pressures (MAPs; mmHg; recorded every half hour); all blood glucose values (mg/dl); number of days of haemodialysis; number of survivors or non-survivors; daily Therapeutic Intervention Scoring System (TISS)-28 scores; 17 daily Simplified Acute Physiology II Scores (SAPS II); 18 and daily Sepsis-related Organ Failure Assessment (SOFA) scores. 19 After an electronic validation procedure, which was performed Randomly matched every patient deceased on ICU to a patient discharged alive according to age, sex and ICU ward Patients analysed in univariate and multivariate analyses (n = 634) Key performance indicators in intensive care medicine daily by the treating physicians, the data became part of each patient's record. The goal value for the RASS (Richmond Agitation-Sedation Scale) 20 was documented once daily by the attending physicians for every patient treated in the ICU. The RASS, visual analogue scale (VAS) or numerical rating scale (NRS) for the assessment of pain, and the behavioural pain scale (BPS) were measured three times a day by nursing staff. The BPS was used to measure pain intensity in ventilated patients and the VAS/NRS was used for patients who were spontaneously breathing, awake and orientated. The measured level of pain was evaluated in terms of outcome rather than the absolute value of the score. Other data, such as blood pressure, laboratory values, ventilator settings and dialysis parameters, were imported electronically into each patient's record and required validation by the ICU staff. The ventilator settings and haemodynamic variables were monitored continuously in the ICU, but were transferred and registered every 30 min in each patient's electronic record.
Early studies correlating the outcome of septic patients with haemodynamic variables often reported haemodynamic variables as single measurements at defined time intervals, or used mean values of several measurements. 21, 22 Other investigators have used the area under the curve for a certain threshold from continuously measured MAP over a given time to estimate the hypotension and 23 In the present study, the continuously measured MAP values were documented every 30 min in each patient's electronic charts. The documentation of three or more values outside the defined range in every 24 h was defined as deviation from the goal values. This model was used for MAP, peak inspiratory pressure (PIP), tidal volume (TV) and blood glucose measurements.
STATISTICAL ANALYSIS
Results are expressed as arithmetic mean ± SD, median (interquartile range) or frequency (%). Comparisons between patient groups were assessed using the exact χ 2 -test or Fisher's test, Student's t-test or the Mann-Whitney U-test, as appropriate. Where there were small and unbalanced sample sizes and/or data with ties and/or sparse observations, all statistical analyses used an exact test. Primary outcome measures (ICU mortality and length of ICU stay) were subjected to both univariate and multivariate analyses using multiple logistic regression and multiple linear regression, respectively. The following variables were entered into regression analyses as risk factors: values of SOFA, TISS and SAPS II for the last day of ICU stay; daily values of RASS; VAS/NRS for non-intubated patients; BPS for intubated patients; TV > 6 ml/kg body weight; MAP < 60 mmHg; and blood glucose > 130 mg/dl or < 80 mg/day. Regression coefficients with 95% confidence intervals (CIs) and the corresponding P-values were calculated for each risk factor. Odds ratios (OR) with 95% CIs were determined in the logistic regression. A two-tailed P-value of < 0.05 was considered to be statistically significant. Because of the exploratory character of the study, no adjustments for multiple testing were made. All numerical calculations were performed using the SPSS ® statistical package, version 14.0 (SPSS Inc., Chicago, IL, USA) for Windows ® , StatXact 5 ® (Cytel Software, Cambridge, MA, USA) and S-PLUS 2000 Professional Release 2 (MathSoft, Cambridge, MA, USA).
Results
The Steering Committee determined five areas on which to focus: respiratory therapy, analgesia, sedation and the control of haemodynamic and metabolic status. Seven indicators were selected reflecting major determinants of care processes that have the potential to induce changes in the course of the treatment process: (i) monitoring of TV and keeping TV ≤ 6 ml/kg predicted body weight; (ii) monitoring PIP and keeping it ≤ 35 cmH 2 O; (iii) monitoring BPS during ventilator therapy and VAS/NRS if the patient was off the ventilator and cooperative; (iv) monitoring the sedation level using the RASS; (v) goal setting of an appropriate sedation level using RASS; (vi) monitoring MAP and keeping it ≥ 60 mmHg; and (vii) monitoring blood glucose level and keeping it ≥ 80 mg/dl and ≤ 130 mg/dl ( Table  1) .
The characteristics of the entire cohort of 4445 patients are given in Table 2 . During the study period, in which the data on these 4445 patients were evaluated, 317 patients (7.1%) died while in the ICU (Fig. 1 ). One patient who was discharged alive from the ICU was randomly assigned to each patient who died during the stay in the ICU, matched according to age, sex and ICU ward.
In total, 634 matched patients were included in the univariate and multivariate analyses and their demographics and clinical characteristics are shown in Table 3 . Their mean ± SD age was 64.63 ± 16.30 years and length of ICU stay was 10.10 ± 14.00 days. The percentage of patients on a and not at all in 58.0%. MAP was not documented at all in 10.1% of patients, no values were < 60 mmHg in 13.1% of patients, there was at least 1 day with three documented values < 60 mmHg in 76.8% of patients and no patient had all days with three documented values < 60 mmHg. The lack of complete documentation for MAP values occurred because, in patients with non-invasive blood pressure monitoring, the MAP values were not automatically calculated and documented by the monitoring system, but non-invasive blood pressure was monitored. These values were not considered in the evaluation because the measurement was of a different type.
Data relating to the measurements of TV, PIP and blood glucose are also shown in Table 3 . The absence of documented values for TV and PIP can be explained by the fact that not all ventilators had an interface to transmit the ventilator settings to the electronic patient charts.
In Table 4 the univariate results for the 317 matched survivors and non-survivors for the different indicators are given and the mulitivariate logistic regression analysis of this matched cohort comparing survivors and non-survivors is presented in Table 5 . The risk factors that were significantly associated with death in the ICU were missing BPS measurement (P < 0.001), missing RASS measurement (P = 0.014), MAP remaining ≥ 60 mmHg (P = 0.002) and blood glucose ≥ 80 mg/dl (P < 0.001). In the multivariate linear regression analysis with length of ICU stay as the dependent variable, missing BPS measurement (P = 0.008), PIP remaining ≤ 35 cmH 2 O (P < 0.001) and TV ≤ 6 ml/kg body weight (P < 0.001) were significant influencing factors (Table 6 ). Multivariate linear regression analysis also showed the number of hours on ventilation was significantly affected by the same factors as the length of ICU stay (P < 0.001 for all factors) ( Table 7) .
The results of the multivariate logistic and linear regression analyses of the complete study population of 4445 patients are given in Tables 8 and 9 . In the multivariate logistic analysis, missing BPS measurements (P < 0.001), MAP ≥ 60 mmHg (P < 0.001), blood glucose ≥ 80 mg/dl (P < 0.001) and PIP ≤ 35 cmH 2 O (P = 0.016) were shown to have significant effects on death in the ICU (Table  8 ). In the multivariate linear regression analysis with length of ICU stay as the dependent variable, the same parameters that had significant effects on death in the ICU influenced the length of stay in the ICU, but with the addition also of blood glucose values ≤ 130 mg/dl (P = 0.038) and TV ≤ 6 ml/kg body weight (P = 0.005) ( Table 9 ). Multivariate linear regression analysis with time on ventilation as the dependent variable showed that all the variables had significant effects (P < 0.001), except for lack of RASS measurements and blood glucose ≤ 130 mg/dl ( Table 10 ). The linear regression analyses for the whole cohort (n = 4445) were performed without the scores for TISS, SAPS II and SOFA in the regression model. When these scores were included, the statistical significances remained unchanged for the variables that were analysed. The TISS, SAPS II and SOFA scores significantly affected length of ICU stay and time on ventilation. 
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Discussion
The most important result of the present study was that the consensus-based key performance indicators of the patient care processes were independent risk factors for mortality, length of ICU stay and duration of ventilation.
Current mortality prediction models comprise physiological parameters. In their validation study of the Intensive Care National Audit and Research Centre model as a tool for risk-adjusted comparisons between critical care units, Harrison et al. 24 pointed out that there is considerable Guidelines) trial demonstrated a striking association between hospital process performance and outcomes among patients with acute coronary syndromes. 25 In a narrative review of the literature, Berenholtz et al. 6 suggested effective assessment of pain, appropriate use of blood transfusions, prevention of ventilator-associated pneumonia, appropriate sedation, appropriate prophylaxis of peptic ulcer disease and appropriate prophylaxis of deep venous thrombosis as process parameters with the highest evidence base and strongest grade of recommendation.
In the present study it was demonstrated that specific process parameters were associated with improved outcome. For process parameters to become widespread measures of accountability and quality management, it is important that they can be implemented with minimal use of resources. All parameters in this study could easily be incorporated into an existing PDMS and were, in fact, automatically collected in the present study. There is great variation in the adoption of evidence-based recommendations. 26 Focusing on key parameters that determine outcome, automated reporting may, therefore, help to make quality reports more comparable.
The present study demonstrated that structured documentation of levels of pain and sedation alone was independently correlated with a better outcome in terms of death in the ICU, and that the measurement of pain influenced the length of time on ventilation and of stay in the ICU. These data agree with controlled trials of sedation and pain management in the ICU. 27 -29 The RASS is easily measured and is highly reliable for the measurement of sedation. 20 The importance of monitoring the sedation level of all patients in the ICU was clearly shown in a study by Kress et al. 27 Several clinical practice guidelines particularly emphasize the need for goal-directed delivery of sedatives to patients in the ICU. 28, 29 The present study demonstrated that the measurement of pain in the ICU influences the length of ICU stay and time on ventilation. In a study by Chanques et al., 30 the impact of systematic evaluation of pain and agitation in the ICU resulted in decreases in the duration of mechanical ventilation and the incidence of nosocomial infections. In a study by Tsui et al., 31 adequate post-operative analgesia was able to reduce overall mortality and hospital mortality, as well as mean hospital stay, in patients after oesophagectomy (n = 578). A study by Brodner et al. 32 confirmed these data by demonstrating that the intervention of an acute pain management service was able to reduce the length of ICU stay in surgical patients (n = 5602); regular assessment of pain formed part of this intervention.
A possible explanation for the better outcome of patients whose pain and sedation levels were monitored might be that they had a decreased stress response Key performance indicators in intensive care medicine associated with pain and agitation. Stress reduction reduces the incidence of tachycardia, decreases myocardial oxygen consumption, reduces hypercoagulability, and leads to immunosuppression and catabolism. 33, 34 The decrease in the duration of mechanical ventilation can be explained by physician and nurse education that encouraged them to decrease or stop analgesics or sedatives in the absence of pain or agitation.
In the present study, length of ICU stay and time on ventilation in mechanically ventilated patients was influenced by ventilation with TV ≤ 6 ml/kg and PIP ≤ 35 cmH 2 O, although ICU mortality was not significantly influenced by either TV or PIP. The need to avoid alveolar over-distension by the use of deleterious ventilatory strategies is commonly accepted. A large multicentre, randomized trial published by the Acute Respiratory Distress Network in 2000 using a volume-and pressure-limited strategy, showed a 9% decrease in overall mortality among patients with acute respiratory distress syndrome or acute lung injury who were ventilated with tidal volumes of 6 ml/kg of predicted body weight, as opposed to 12 ml/kg and aiming at a plateau pressure ≤ 30 cmH 2 O. 35 In a recently published study by Mercat et al., 36 a strategy for setting positive end-expiratory pressure that was designed to increase alveolar recruitment while limiting hyperinflation (with a fixed TV of 6 ml/kg body weight) in 767 patients with acute lung injury did not significantly reduce mortality, but it did reduce the duration of mechanical ventilation. Deciding which pressure/tidal volumes should be considered optimal and which mode of ventilation is best is still the subject of debate. 37 In findings similar to the present study, Esteban et al. 38 determined the survival of patients receiving mechanical ventilation in a large international prospective observational study and were able to demonstrate that plateau pressures > 35 cmH 2 O were associated with an increased risk of death. The patient population in the present study included all patients on ventilation, independently of the diagnosis of acute respiratory distress syndrome or acute lung injury.
A statistically significant relationship between MAP ≥ 60 mmHg and the outcome variable of mortality for the matched cohort patients was demonstrated in the present study. For all patients (n = 4445), the MAP affected death, length of stay in the ICU and time on ventilation. As has been shown in other studies, MAP appears to be an important treatment goal in ensuring adequate perfusion pressure for vital organs. 23,39 -41 Several trials have included goals for MAP as a treatment goal in septic patients using early goal-directed therapy flow charts 42 and MAP has also been included in international guidelines for the treatment of sepsis and septic shock. 43 In the present study, blood glucose > 130 mg/dl was significantly correlated with length of ICU stay for both ventilated patients and non-ventilated patients. Only days with three or more documented blood glucose values above this level were considered. Blood glucose < 80 mg/dl also affected length of ICU stay. Mortality was significantly affected by values < 80 mg/dl, irrespective of whether the patient was mechanically ventilated. In the present evaluation, days with more than one value < 80 mg/dl were considered. In a large singlecentre trial among predominantly cardiac surgery patients, Van den Berghe et al. 44 were able to reduce ICU mortality (median unbiased estimate of 32% mortality reduction for all patients) by the intensive use of intravenous insulin with the aim of Key performance indicators in intensive care medicine maintaining blood glucose levels between 80 and 110 mg/dl. A second randomized trial by Van den Berghe et al., 45 of intensive insulin therapy using the same protocol, enrolled medical ICU patients. In this trial of 1200 patients, mortality was not reduced but length of ICU and hospital stay were reduced and earlier weaning from mechanical ventilation was possible. Remarkably, 18% of patients became hypoglycaemic in this medical ICU, compared with 6.2% in the surgical ICU. A meta-analysis of 35 trials examining insulin therapy and hospital mortality by Pittas et al. 46 showed an average reduction in mortality of 15%. This systematic review did not include studies of insulin therapy in medical ICUs. Two additional multicentre, randomized, controlled trials of intensive insulin therapy, one focusing on patients with severe sepsis (Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis [VISEP]) 47 and the second on medical and surgical ICU patients, 48 failed to demonstrate improvement in mortality, and both trials were stopped earlier than planned because of high rates of hypoglycaemia and adverse events in the groups receiving intensive insulin treatment. Data collection in the present study, from a mixed population of ICU patients using similar insulin guidelines, demonstrated only 0.2% of all recorded blood glucose values (n = 319 958) were ≤ 40 mg/dl (data not shown), which was the level defined as severe hypoglycaemia for the VISEP study group. 47 The present study performed a retrospective analysis of data from a PDMS system, so the results should be interpreted with caution. In addition, monitoring of delirium was not routinely used at the beginning of the study period and delirium has been reported to be a relevant outcome predictor and found to be associated with a three-fold increased risk of death in ventilated patients. 49 Since the present trial was based in one hospital, results for other facilities may vary due to local circumstances and variations in policies between different institutions. The patients treated in the five surgical ICUs at the Charité University Medicine Berlin were predominantly post-operative. For other ICUs with different patient population, the results might differ.
Despite these limitations, indicators of ICU quality are urgently required. A review by Pronovost et al. 4 analysed interventions in ICU patients to estimate the effects of therapy delivered according to evidencebased medicine. These authors showed that 137 670 -197 965 lives of critically ill patients could be saved each year by implementing the five interventions they investigated. There remains a major shortfall in the implementation of therapies in daily clinical practice that have been proved to be effective. Following the introduction of a reporting system, strategies to improve treatment can be introduced. A key issue is the ability to collect data and report results on performance quickly by the use of the new generation of data information systems. 50 In the present study, data that were already available from the PDMS information system were used to evaluate key process indicators for their effects on outcome. It was possible to show the relevance of the key performance indicators that had been defined on the outcomes of intensive care patients. Further studies are needed to demonstrate what effect the integration and targeted management of these key performance indicators within the PDMS system will have on final outcome. Current research strategies that focus on the understanding of disease pathology and the development of new therapies need to be reconsidered in a way that ensures that patients receive the evidence-based therapies that they ought to receive. During the development of new guidelines, special attention should be paid to the fact that the implementation of new guidelines needs to be monitored in terms of adherence to the guidelines, thereby ensuring defined optimal outcomes for patients.
The goal of the present study was to develop a set of valid but reliable and practical measures of the quality of ICU care for defined processes and to estimate their effects on clinical outcome parameters. The outcome variables of length of stay in the ICU, duration of mechanical ventilation and mortality can be affected by the following key process indicators: measurement of sedation; pain; MAP; blood glucose levels; and limitation of TV and PIP. Further studies are needed to evaluate whether the immediate availability of these process indicators in the daily clinical routine can change behaviour and improve outcomes.
